Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


German breast cancer DMP (disease management programme) sparks controversy

This article was originally published in Clinica

Executive Summary

The leading groups of the German statutory health insurance groups (GKV) have reacted with dismay to suggestions by German Cancer Society (DKG) that the government's disease management programme (DMP) for breast cancer is inadequate. "It is incomprehensible that this professional body is trying to distance itself from a programme which it helped develop only a few weeks ago," said the GKV. Rolf Kreienberg, who was president of the society at the time of the DMP's creation, was instrumental in defining the contents of the programme, it added.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts